Credit: Gan & Lee Pharmaceuticals website

Chi­nese biotech boasts com­pet­i­tive Phase 2b weight loss da­ta for GLP-1 drug

Fresh off Eli Lil­ly’s tirzepatide ap­proval for weight loss in Chi­na, Bei­jing-based Gan & Lee Phar­ma­ceu­ti­cals post­ed Phase 2b da­ta of its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.